Understanding MTHFR and Methylation: Energy, Mood and Long-Term Health

Persistent fatigue, poor concentration, low mood, disrupted sleep and unusual sensitivities to medications or supplements can be difficult to understand, particularly when standard investigations provide few answers. These symptoms may involve several interconnected physiological processes, including nutrient metabolism, thyroid function, inflammation, energy production and nervous-system regulation. Methylation is one important part of this wider biochemical picture. My work focuses on understanding the relationships between symptoms, medical history and underlying physiology, especially when someone has experienced years of fragmented treatment without a satisfactory explanation for their continuing difficulties.

Methylation involves the transfer of methyl groups between molecules, supporting essential processes including DNA synthesis, cellular maintenance and homocysteine metabolism. The MTHFR enzyme participates in the folate cycle, alongside other pathways involving vitamin B12, vitamin B6, choline and related nutrients. Through Lifecode Gx genetic testing, I can examine variations in MTHFR, MTR, MTRR, COMT and other genes associated with these biochemical processes. Common genetic variations do not necessarily indicate impaired methylation, so I consider them alongside relevant laboratory markers, particularly homocysteine, folate and vitamin B12 status, to establish whether there is evidence of an underlying functional problem.

A detailed assessment also considers factors that may place additional demands on these pathways or produce similar symptoms. Digestive disorders can interfere with nutrient absorption, while certain medications, including long-term acid suppression and metformin, can contribute to vitamin B12 deficiency. Thyroid dysfunction, metabolic disturbances, chronic inflammation and nutritional inadequacies may also influence energy, cognition and general wellbeing. Where appropriate, I use functional laboratory investigations to examine nutritional and metabolic patterns, interpreting the results in relation to symptoms, medication history and existing medical findings. This allows me to identify concerns that may be overlooked when symptoms are considered individually.

Supporting methylation requires an individualised approach, particularly for people who are sensitive to supplementation or have previously reacted poorly to treatment. I consider nutritional intake, the forms and amounts of nutrients used, gastrointestinal function, sleep, stress physiology and the person's overall capacity to tolerate interventions. Methylated B vitamins are not automatically appropriate for everyone, and genetic findings alone do not determine supplementation. Drawing on my experience in psychotherapy, functional medicine and homeopathy, I consider both physiological and emotional influences on health, developing a carefully paced approach that addresses identifiable biochemical concerns while supporting psychological wellbeing and longer-term resilience.